Shanghai Haoyuan Chemexpress Co. Ltd. A Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Shanghai Haoyuan Chemexpress Co. Ltd. A cash flow conversion efficiency. Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥107.21 Million ≈ $15.69 Million USD) by net assets (CN¥3.13 Billion ≈ $458.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2025)

Cash flow conversion efficiency of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2025. This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688131 stock price for real-time trading data and today's change.

Shanghai Haoyuan Chemexpress Co. Ltd. A Cash Flow Conversion Ratio Explained

Shanghai Haoyuan Chemexpress Co. Ltd. A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A ranked by their cash flow conversion efficiency. Also see Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Anhui Expressway Co Ltd
SHG:600012
0.072x
Ideaya Biosciences Inc
NASDAQ:IDYA
-0.136x
National Storage REIT
AU:NSR
0.018x
Cal-Maine Foods Inc
NASDAQ:CALM
0.002x
AIR CHINA LTD H ADR/20
F:AD2B
N/A
Virbac SA
PA:VIRP
0.023x
Vidrala SA
MC:VID
0.048x
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
0.193x

Annual Cash Flow Conversion Efficiency for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2025. Review free cash flow generation of Shanghai Haoyuan Chemexpress Co. Ltd. A to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥9.43 Billion
≈ $1.38 Billion
CN¥317.75 Million
≈ $46.50 Million
0.034x -74.37%
2024-12-31 CN¥2.90 Billion
≈ $424.98 Million
CN¥381.96 Million
≈ $55.89 Million
0.132x +633.61%
2023-12-31 CN¥2.53 Billion
≈ $369.67 Million
CN¥-62.27 Million
≈ $-9.11 Million
-0.025x +76.07%
2022-12-31 CN¥2.33 Billion
≈ $341.24 Million
CN¥-240.23 Million
≈ $-35.15 Million
-0.103x -427.11%
2021-12-31 CN¥1.84 Billion
≈ $268.73 Million
CN¥57.83 Million
≈ $8.46 Million
0.031x -85.77%
2020-12-31 CN¥527.81 Million
≈ $77.24 Million
CN¥116.79 Million
≈ $17.09 Million
0.221x +54.98%
2019-12-31 CN¥399.73 Million
≈ $58.49 Million
CN¥57.07 Million
≈ $8.35 Million
0.143x -10.78%
2018-12-31 CN¥177.65 Million
≈ $26.00 Million
CN¥28.43 Million
≈ $4.16 Million
0.160x +72.73%
2017-12-31 CN¥114.74 Million
≈ $16.79 Million
CN¥10.63 Million
≈ $1.56 Million
0.093x +143.20%
2016-12-31 CN¥56.86 Million
≈ $8.32 Million
CN¥-12.19 Million
≈ $-1.78 Million
-0.214x -484.77%
2015-12-31 CN¥32.65 Million
≈ $4.78 Million
CN¥1.82 Million
≈ $266.30K
0.056x +146.55%
2014-12-31 CN¥33.10 Million
≈ $4.84 Million
CN¥-3.96 Million
≈ $-579.94K
-0.120x -197.57%
2013-12-31 CN¥9.70 Million
≈ $1.42 Million
CN¥1.19 Million
≈ $174.12K
0.123x --

About Shanghai Haoyuan Chemexpress Co. Ltd. A

SHG:688131 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.01 Billion
CN¥20.59 Billion CNY
Market Cap Rank
#4739 Global
#744 in China
Share Price
CN¥97.09
Change (1 day)
-3.87%
52-Week Range
CN¥60.36 - CN¥110.37
All Time High
CN¥148.50
About

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.